<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">AJS</journal-id>
<journal-id journal-id-type="hwp">amjsports</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Sports Med</journal-id>
<journal-title>The American Journal of Sports Medicine</journal-title>
<issn pub-type="ppub">0363-5465</issn>
<issn pub-type="epub">1552-3365</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0363546513493767</article-id>
<article-id pub-id-type="publisher-id">10.1177_0363546513493767</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letters to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Platelet-Rich Plasma Treatment for Lateral Epicondylitis: Letter to the Editor</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Wilson</surname><given-names>John J.</given-names></name>
<degrees>MD, MS</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Rabago</surname><given-names>David P.</given-names></name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Lee</surname><given-names>Kenneth S.</given-names></name>
<degrees>MD</degrees>
</contrib>
</contrib-group>
<author-notes>
<corresp id="corresp1-0363546513493767">John J. Wilson, MD, MS (e-mail: <email>wilson@ortho.wisc.edu</email>).</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>7</month>
<year>2013</year>
</pub-date>
<volume>41</volume>
<issue>7</issue>
<fpage>NP33</fpage>
<lpage>NP35</lpage>
<permissions>
<copyright-statement>© 2013 The Author(s)</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">American Orthopaedic Society for Sports Medicine</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p><bold>Dear Editor:</bold></p>
<p>In their randomized controlled trial (RCT), Dr Krogh and colleagues<sup><xref ref-type="bibr" rid="bibr8-0363546513493767">8</xref></sup> compared platelet-rich plasma (PRP) injection with glucocorticoid and saline injections for chronic lateral epicondylosis (CLE). Improvements in primary and secondary outcomes were not statistically different between groups, and the study was reported as negative. We commend the authors for their rigorous 12-month study; they acknowledge the difficulties associated with participant attrition and the need to report limited 3-month data. They concluded that they were unable to corroborate prior positive results for PRP but that both PRP and corticosteroid injections are safe.</p>
<p>Our academic university practice uses PRP for treatment of tendinopathies; the authors’ conclusions differ from our experience. In the interest of clinical context and rigorous future assessment of PRP, we offer the following observations and suggestions.</p>
<p>We postulate that 4 elements in the design, conduct, and reporting of this study may have minimized the ability to meaningfully detect a potential effect of PRP.</p>
<list id="list1-0363546513493767" list-type="order">
<list-item><p>Our clinical experience is that improvement in pain and functional outcomes after PRP treatment can be slow; often effects are not evident until after 3 months or more. Studies that have evaluated common extensor tendon healing after therapeutic injections, including PRP, have consistently demonstrated that best effects were not evident until an average of 6 months after treatment.<sup><xref ref-type="bibr" rid="bibr9-0363546513493767">9</xref>,<xref ref-type="bibr" rid="bibr7-0363546513493767">7</xref>,<xref ref-type="bibr" rid="bibr13-0363546513493767">13</xref></sup> We agree with the authors’ cautious approach to interpretation of these 3-month data.</p></list-item>
<list-item><p>The potential biological effect of the PRP injection, even in the early stages of healing, may have been minimized by 2 aspects of the protocol. First, the researchers injected a large volume (10-15 mL) of lidocaine into the peritendinous tissue in all subjects, which departs from the standard of care for most physicians using PRP.<sup><xref ref-type="bibr" rid="bibr9-0363546513493767">9</xref></sup> Carofino et al<sup><xref ref-type="bibr" rid="bibr3-0363546513493767">3</xref></sup> have reported that lidocaine exerts inhibitory effects on tenocyte proliferation in the presence of PRP. Second, sodium citrate was used as an anticoagulant in the preparation of PRP, which is reported to have inhibitory effects on platelet aggregation and activation in PRP.<sup><xref ref-type="bibr" rid="bibr2-0363546513493767">2</xref>,<xref ref-type="bibr" rid="bibr6-0363546513493767">6</xref></sup> These procedures may have rendered PRP less active or even inactive. The results at 3 months and the per protocol analysis at 12 months demonstrating no difference between saline and PRP groups may therefore be partially due to inadvertent diminution of PRP effect.</p></list-item>
<list-item><p>The Patient-Rated Tennis Elbow Evaluation (PRTEE) outcome measure was used in an unconventional manner, and the power calculation was based on a very large between-group effect on the PRTEE pain subscale, not the instrument as a whole. Therefore, the assessment and analysis scheme, although well described, may be overly optimistic and therefore unlikely to detect a statistically significant difference between groups even under ideal clinical circumstances. Specifically, the PRTEE is designed as a 100-point scale<sup><xref ref-type="bibr" rid="bibr12-0363546513493767">12</xref></sup> (50 points for pain and 100/2 points for function), not the 150 points reported here. The minimal clinical important difference (“much better” or “completely recovered”) on the PRTEE has been reported as an 11-point change on the 100-point PRTEE as a whole.<sup><xref ref-type="bibr" rid="bibr10-0363546513493767">10</xref></sup> The authors powered their study to detect a <italic>difference in change between groups</italic> of 10 out of only 50 possible points on the PRTEE pain subscale, a very large effect size among a small number of points, the statistically significant detection of which seems unlikely even if the PRP effect was very large. And although scales can be appropriately modified, the use of a 150-point analysis of the PRTEE may render these results less comparable with studies using the more conventional 100-point method.</p></list-item>
<list-item><p>The authors’ conclusion that both PRP and corticosteroid injections can be used safely may be premature (for PRP) or incorrect (for corticosteroids). Although this study does not report adverse events, it is also not powered to detect rare occurrences; the short duration further limits the claim to overall safety. More important, the comparison with glucocorticoid injections, although standard in lateral epicondylosis research, has become more controversial in recent years. Although data support some effectiveness for short-term pain relief in the treatment of epicondylosis,<sup><xref ref-type="bibr" rid="bibr1-0363546513493767">1</xref></sup> evidence is building that corticosteroid injections result in worse outcomes, compared, for example, with physical therapy alone at 1 year.<sup><xref ref-type="bibr" rid="bibr4-0363546513493767">4</xref></sup></p></list-item>
</list>
<p>Determining the optimal trial design and choice of control treatment against which to assess therapies for CLE remains challenging, given the clinical popularity of corticosteroid injection, the need for a blindable control, and the nontrivial clinical effect of saline injections.<sup><xref ref-type="bibr" rid="bibr11-0363546513493767">11</xref></sup> Clinical trialists have acknowledged the pressure to select against study designs with clinically relevant but nonblindable control groups, such as exercise, in the interest of perceived methodological rigor.<sup><xref ref-type="bibr" rid="bibr5-0363546513493767">5</xref></sup> Determining the effect of PRP in meaningful clinical settings may thereby suffer. Future assessment of PRP would benefit from comparison with both saline control and noninjection standard of care control groups.</p>
<sig-block>
<sig>John J. Wilson, MD, MS<break/>
David P. Rabago, MD<break/>
Kenneth S. Lee, MD<break/>
<italic>Madison, Wisconsin</italic></sig>
</sig-block>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<p>The authors declared that they have no conflicts of interest in the authorship and publication of this contribution.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0363546513493767">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bisset</surname><given-names>L</given-names></name>
<name><surname>Coombes</surname><given-names>B</given-names></name>
<name><surname>Vicenzino</surname><given-names>B</given-names></name>
</person-group>. <article-title>Tennis elbow</article-title>. <source>Clin Evid (Online)</source>. <year>2011</year>;<volume>1117</volume>. Published <month>June</month> <day>27</day>, <year>2011</year>. doi: pii: <fpage>1117</fpage>.</citation>
</ref>
<ref id="bibr2-0363546513493767">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Callan</surname><given-names>MB</given-names></name>
<name><surname>Shofer</surname><given-names>FS</given-names></name>
<name><surname>Catalfamo</surname><given-names>JL</given-names></name>
</person-group>. <article-title>Effects of anticoagulant on pH, ionized calcium concentration, and agonist-induced platelet aggregation in canine platelet-rich plasma</article-title>. <source>Am J Vet Res</source>. <year>2009</year>;<volume>70</volume>(<issue>4</issue>):<fpage>472</fpage>-<lpage>477</lpage>.</citation>
</ref>
<ref id="bibr3-0363546513493767">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carofino</surname><given-names>B</given-names></name>
<name><surname>Chowaniec</surname><given-names>DM</given-names></name>
<name><surname>McCarthy</surname><given-names>MB</given-names></name><etal/>
</person-group>. <article-title>Corticosteroids and local anesthetics decrease positive effects of platelet-rich plasma: an in vitro study on human tendon cells</article-title>. <source>Arthroscopy</source>. <year>2012</year>;<volume>28</volume>(<issue>5</issue>):<fpage>711</fpage>-<lpage>719</lpage>.</citation>
</ref>
<ref id="bibr4-0363546513493767">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Coombes</surname><given-names>BK</given-names></name>
<name><surname>Bisset</surname><given-names>L</given-names></name>
<name><surname>Brooks</surname><given-names>P</given-names></name>
<name><surname>Khan</surname><given-names>A</given-names></name>
<name><surname>Vicenzino</surname><given-names>B</given-names></name>
</person-group>. <article-title>Effect of corticosteroid injection, physiotherapy, or both on clinical outcomes in patients with unilateral lateral epicondylalgia: a randomized controlled trial</article-title>. <source>JAMA</source>. <year>2013</year>;<volume>309</volume>(<issue>5</issue>):<fpage>461</fpage>-<lpage>469</lpage>.</citation>
</ref>
<ref id="bibr5-0363546513493767">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>de Vos</surname><given-names>RJ</given-names></name>
<name><surname>Tol</surname><given-names>JL</given-names></name>
<name><surname>Verhaar</surname><given-names>JAN</given-names></name>
</person-group>. <article-title>Platelet-rich plasma for treatment of Achilles tendinopathy—reply</article-title>. <source>JAMA</source>. <year>2010</year>;<volume>303</volume>(<issue>17</issue>):<fpage>1696</fpage>-<lpage>1698</lpage>.</citation>
</ref>
<ref id="bibr6-0363546513493767">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dwyer</surname><given-names>SD</given-names></name>
<name><surname>Meyers</surname><given-names>KM</given-names></name>
</person-group>. <article-title>Anesthetics and anticoagulants used in the preparation of rat platelet-rich-plasma alter rat platelet aggregation</article-title>. <source>Thromb Res</source>. <year>1986</year>;<volume>42</volume>(<issue>2</issue>):<fpage>139</fpage>-<lpage>151</lpage>.</citation>
</ref>
<ref id="bibr7-0363546513493767">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gosens</surname><given-names>T</given-names></name>
<name><surname>Peerbooms</surname><given-names>JC</given-names></name>
<name><surname>van Laar</surname><given-names>W</given-names></name>
<name><surname>den Oudsten</surname><given-names>BL</given-names></name>
</person-group>. <article-title>Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up</article-title>. <source>Am J Sports Med</source>. <year>2011</year>;<volume>39</volume>(<issue>6</issue>):1200-<year>1208</year>.</citation>
</ref>
<ref id="bibr8-0363546513493767">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Krogh</surname><given-names>TP</given-names></name>
<name><surname>Fredberg</surname><given-names>U</given-names></name>
<name><surname>Stengaard-Pedersen</surname><given-names>K</given-names></name>
<name><surname>Christensen</surname><given-names>R</given-names></name>
<name><surname>Jensen</surname><given-names>P</given-names></name>
<name><surname>Ellingsen</surname><given-names>T</given-names></name>
</person-group>. <article-title>Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline: a randomized, double-blind, placebo-controlled trial</article-title>. <source>Am J Sports Med</source>. <year>2013</year>;<volume>41</volume>(<issue>3</issue>):<fpage>625</fpage>-<lpage>635</lpage>.</citation>
</ref>
<ref id="bibr9-0363546513493767">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Peerbooms</surname><given-names>JC</given-names></name>
<name><surname>Sluimer</surname><given-names>J</given-names></name>
<name><surname>Bruijn</surname><given-names>DJ</given-names></name>
<name><surname>Gosens</surname><given-names>T</given-names></name>
</person-group>. <article-title>Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up</article-title>. <source>Am J Sports Med</source>. <year>2010</year>;<volume>38</volume>(<issue>2</issue>):<fpage>255</fpage>-<lpage>262</lpage>.</citation>
</ref>
<ref id="bibr10-0363546513493767">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Poltawski</surname><given-names>L</given-names></name>
<name><surname>Watson</surname><given-names>T</given-names></name>
</person-group>. <article-title>Measuring clinically important change with the Patient-rated Tennis Elbow Evaluation</article-title>. <source>Hand Therapy</source>. <year>2011</year>;<volume>16</volume>(<issue>3</issue>):<fpage>52</fpage>-<lpage>57</lpage>.</citation>
</ref>
<ref id="bibr11-0363546513493767">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rabago</surname><given-names>D</given-names></name>
<name><surname>Wilson</surname><given-names>J</given-names></name>
<name><surname>Zgierska</surname><given-names>A</given-names></name>
</person-group>. <article-title>Platelet-rich plasma for treatment of Achilles tendinopathy</article-title>. <source>JAMA</source>. <year>2010</year>;<volume>303</volume>(<issue>17</issue>):<fpage>1696</fpage>-<lpage>1697</lpage>; author reply <fpage>1697</fpage>-<lpage>1698</lpage>.</citation>
</ref>
<ref id="bibr12-0363546513493767">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rompe</surname><given-names>JD</given-names></name>
<name><surname>Overend</surname><given-names>TJ</given-names></name>
<name><surname>MacDermid</surname><given-names>JC</given-names></name>
</person-group>. <article-title>Validation of the patient-rated tennis elbow evaluation questionnaire</article-title>. <source>J Hand Ther</source>. <year>2007</year>;<volume>20</volume>(<issue>1</issue>):<fpage>3</fpage>-<lpage>10</lpage>; quiz <fpage>11</fpage>.</citation>
</ref>
<ref id="bibr13-0363546513493767">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wolf</surname><given-names>JM</given-names></name>
<name><surname>Ozer</surname><given-names>K</given-names></name>
<name><surname>Scott</surname><given-names>F</given-names></name>
<name><surname>Gordon</surname><given-names>MJV</given-names></name>
<name><surname>Williams</surname><given-names>AE</given-names></name>
</person-group>. <article-title>Comparison of autologous blood, corticosteroid, and saline injection in the treatment of lateral epicondylitis: a prospective, randomized, controlled multicenter study</article-title>. <source>J Hand Surg</source>. <year>2011</year>;<volume>36</volume>(<issue>8</issue>):<fpage>1269</fpage>-<lpage>1272</lpage>.</citation>
</ref>
</ref-list>
</back>
<sub-article article-type="letter" id="sub1-0363546513493767">
<front-stub>
<title-group>
<article-title>Response</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Krogh</surname><given-names>Thøger Persson</given-names></name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Fredberg</surname><given-names>Ulrich</given-names></name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Stengaard-Pedersen</surname><given-names>Kristian</given-names></name>
<degrees>MD, DMSc</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Christensen</surname><given-names>Robin</given-names></name>
<degrees>MSc, PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Jensen</surname><given-names>Pia</given-names></name>
<degrees>RN</degrees>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Ellingsen</surname><given-names>Torkell</given-names></name>
<degrees>MD, PhD</degrees>
</contrib>
</contrib-group>
<author-notes>
<corresp id="corresp2-0363546513493767">Torkell Ellingsen, MD, PhD (e-mail: <email>torkell@dadlnet.dk</email>).</corresp>
</author-notes>
</front-stub>
<body>
<p><bold>Authors’ Response:</bold></p>
<p>We thank Dr Wilson and colleagues for raising important points in relation to the clinical use of PRP in the treatment of lateral epicondylitis. Issues such as PRP preparation technique, dose-response of PRP, use of citrate to prevent coagulation, volume of local anesthetics, injection technique, observation period, and standardized outcome parameters are not internationally standardized and differ between previous studies.<sup><xref ref-type="bibr" rid="bibr18-0363546513493767">5</xref>,<xref ref-type="bibr" rid="bibr22-0363546513493767">9</xref>,<xref ref-type="bibr" rid="bibr23-0363546513493767">10</xref>,<xref ref-type="bibr" rid="bibr27-0363546513493767">14</xref></sup></p>
<p>As discussed in the article, tendon healing is a slow process, and we agree with Dr Wilson and colleagues that patients should ideally be followed as long as possible. In our study, the pain level made it difficult and ethically debatable to keep patients in a blinded RCT study for longer than 3 months.<sup><xref ref-type="bibr" rid="bibr20-0363546513493767">7</xref></sup> The previous 4 studies assessing treatment with PRP for lateral epicondylitis had already reported a pain-reducing effect at 3 months when compared with baseline.<sup><xref ref-type="bibr" rid="bibr18-0363546513493767">5</xref>,<xref ref-type="bibr" rid="bibr22-0363546513493767">9</xref>,<xref ref-type="bibr" rid="bibr23-0363546513493767">10</xref>,<xref ref-type="bibr" rid="bibr27-0363546513493767">14</xref></sup> These results, however, are difficult to interpret since only 1 trial, a cohort study,<sup><xref ref-type="bibr" rid="bibr9-0363546513493767">9</xref></sup> included a placebo group.</p>
<p>In 3 of 4 previous lateral epicondylitis trials investigating PRP effect, a local anesthetic was applied intratendinously<sup><xref ref-type="bibr" rid="bibr22-0363546513493767">9</xref>,<xref ref-type="bibr" rid="bibr23-0363546513493767">10</xref></sup> and/or peritendiously,<sup><xref ref-type="bibr" rid="bibr18-0363546513493767">5</xref>,<xref ref-type="bibr" rid="bibr22-0363546513493767">9</xref></sup> and in our recent network meta-analysis, 12 of 17 trials (70%) used local anesthetics.<sup><xref ref-type="bibr" rid="bibr19-0363546513493767">6</xref></sup> This finding demonstrates that local anesthetics are frequently used in lateral epicondylitis research. In the prestudy phase we found that injecting PRP into the common extender tendon was very painful. This might be explained by the relatively large volume of PRP injected into a small tendon area. However, we used 3 mL of PRP, as done in the other studies.<sup><xref ref-type="bibr" rid="bibr20-0363546513493767">7</xref></sup></p>
<p>In the previous 4 in vivo PRP studies, up to 2 mL of local anesthetic was used followed by injection of 3 mL of PRP. Three of the studies used sodium citrate in unknown concentrations. First, we infiltrated with 10 mL of local anesthetics peritendinously, followed by injection of 3 mL of PRP. Our technique used a larger volume of local anesthetics, and we cannot rule out a possible negative effect of this but it is not likely. Second, we stabilized the platelets with sodium citrate as done in the other studies, and again we cannot rule out a negative effect. However, possible negative effects of citrate and local anesthetics on the healing of tendons are based on data from in vitro studies,<sup><xref ref-type="bibr" rid="bibr15-0363546513493767">2</xref>,<xref ref-type="bibr" rid="bibr16-0363546513493767">3</xref></sup> and in vivo studies are needed to answer questions about the clinical effect.</p>
<p>In our study we used the PRTEE questionnaire.<sup><xref ref-type="bibr" rid="bibr21-0363546513493767">8</xref>,<xref ref-type="bibr" rid="bibr24-0363546513493767">11</xref></sup> Our primary outcome was change in pain, which is why we used the pain subscale and function subscale separately as allowed by the developer of this questionnaire.<sup><xref ref-type="bibr" rid="bibr21-0363546513493767">8</xref></sup> We did not, however, report the total PRTEE score. We agree that it might be easier to compare different studies if only the total PRTEE score is reported as a primary outcome.</p>
<p>In the Safety section in our article we reported side effects as observed in our study. We agree that hypothetical speculations regarding rare occurrences are unlikely to be recognized in small trials. It would take very large studies and long follow-up periods to detect rare occurrences. In lateral epicondylitis research, the best chance of detecting rare side effects would be by collecting data from various trials. In a recent network meta-analysis, we looked at the comparative effectiveness of various injection therapies and side effects.<sup><xref ref-type="bibr" rid="bibr19-0363546513493767">6</xref></sup></p>
<p>Tendons have natural healing properties over long time,<sup><xref ref-type="bibr" rid="bibr14-0363546513493767">1</xref>,<xref ref-type="bibr" rid="bibr17-0363546513493767">4</xref>,<xref ref-type="bibr" rid="bibr19-0363546513493767">6</xref>,<xref ref-type="bibr" rid="bibr26-0363546513493767">13</xref></sup> and no well-documented, long-lasting, effective injection therapies for lateral epicondylitis are available.<sup><xref ref-type="bibr" rid="bibr19-0363546513493767">6</xref></sup> Before any recommendations can be made on the use of PRP in the treatment of lateral epicondylitis, it is necessary to conduct more well-designed RCTs following the consort recommendations<sup><xref ref-type="bibr" rid="bibr25-0363546513493767">12</xref></sup> and compare active treatment to placebo for 6 to 12 months.</p>
<sig-block>
<sig>Thøger Persson Krogh, MD<break/>
Ulrich Fredberg, MD, PhD<break/>
<italic>Silkeborg, Denmark</italic><break/>
Kristian Stengaard-Pedersen, MD, DMSc<break/>
<italic>Aarhus, Denmark</italic><break/>
Robin Christensen, MSc, PhD<break/>
<italic>Frederiksberg, Denmark</italic><break/>
Pia Jensen, RN<break/>
Torkell Ellingsen, MD, PhD<break/>
<italic>Silkeborg, Denmark</italic></sig>
</sig-block>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<p>The authors declared that they have no conflicts of interest in the authorship and publication of this contribution.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr14-0363546513493767">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bisset</surname><given-names>L</given-names></name>
<name><surname>Beller</surname><given-names>E</given-names></name>
<name><surname>Jull</surname><given-names>G</given-names></name>
<name><surname>Brooks</surname><given-names>P</given-names></name>
<name><surname>Darnell</surname><given-names>R</given-names></name>
<name><surname>Vicenzino</surname><given-names>B</given-names></name>
</person-group>. <article-title>Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial</article-title>. <source>BMJ</source>. <year>2006</year>;<volume>333</volume>:<fpage>939</fpage>.</citation>
</ref>
<ref id="bibr15-0363546513493767">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Callan</surname><given-names>MB</given-names></name>
<name><surname>Shofer</surname><given-names>FS</given-names></name>
<name><surname>Catalfamo</surname><given-names>JL</given-names></name>
</person-group>. <article-title>Effects of anticoagulant on pH, ionized calcium concentration, and agonist-induced platelet aggregation in canine platelet-rich plasma</article-title>. <source>Am J Vet Res</source>. <year>2009</year>;<volume>70</volume>:<fpage>472</fpage>-<lpage>477</lpage>.</citation>
</ref>
<ref id="bibr16-0363546513493767">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carofino</surname><given-names>B</given-names></name>
<name><surname>Chowaniec</surname><given-names>DM</given-names></name>
<name><surname>McCarthy</surname><given-names>MB</given-names></name><etal/>
</person-group>. <article-title>Corticosteroids and local anesthetics decrease positive effects of platelet-rich plasma: an in vitro study on human tendon cells</article-title>. <source>Arthroscopy</source>. <year>2012</year>;<volume>28</volume>:<fpage>711</fpage>-<lpage>719</lpage>.</citation>
</ref>
<ref id="bibr17-0363546513493767">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Coombes</surname><given-names>BK</given-names></name>
<name><surname>Bisset</surname><given-names>L</given-names></name>
<name><surname>Brooks</surname><given-names>P</given-names></name>
<name><surname>Khan</surname><given-names>A</given-names></name>
<name><surname>Vicenzino</surname><given-names>B</given-names></name>
</person-group>. <article-title>Effect of corticosteroid injection, physiotherapy, or both on clinical outcomes in patients with unilateral lateral epicondylalgia: a randomized controlled trial</article-title>. <source>JAMA</source>. <year>2013</year>;<volume>309</volume>:<fpage>461</fpage>-<lpage>469</lpage>.</citation>
</ref>
<ref id="bibr18-0363546513493767">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Creaney</surname><given-names>L</given-names></name>
<name><surname>Wallace</surname><given-names>A</given-names></name>
<name><surname>Curtis</surname><given-names>M</given-names></name>
<name><surname>Connell</surname><given-names>D</given-names></name>
</person-group>. <article-title>Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections</article-title>. <source>Br J Sports Med</source>. <year>2011</year>;<volume>45</volume>:<fpage>966</fpage>-<lpage>971</lpage>.</citation>
</ref>
<ref id="bibr19-0363546513493767">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Krogh</surname><given-names>TP</given-names></name>
<name><surname>Bartels</surname><given-names>EM</given-names></name>
<name><surname>Ellingsen</surname><given-names>T</given-names></name><etal/>
</person-group>. <article-title>Comparative effectiveness of injection therapies in lateral epicondylitis: a systematic review and network meta-analysis of randomized controlled trials</article-title>. <source>Am J Sports Med</source>. <year>2013</year>;<volume>41</volume>:<fpage>1435</fpage>-<lpage>1446</lpage>.</citation>
</ref>
<ref id="bibr20-0363546513493767">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Krogh</surname><given-names>TP</given-names></name>
<name><surname>Fredberg</surname><given-names>U</given-names></name>
<name><surname>Stengaard-Pedersen</surname><given-names>K</given-names></name>
<name><surname>Christensen</surname><given-names>R</given-names></name>
<name><surname>Jensen</surname><given-names>P</given-names></name>
<name><surname>Ellingsen</surname><given-names>T</given-names></name>
</person-group>. <article-title>Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline: a randomized, double-blind, placebo-controlled trial</article-title>. <source>Am J Sports Med</source>. <year>2013</year>;<volume>41</volume>:<fpage>625</fpage>-<lpage>635</lpage>.</citation>
</ref>
<ref id="bibr21-0363546513493767">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Macdermid</surname><given-names>J</given-names></name>
</person-group>. <article-title>Update: the Patient-rated Forearm Evaluation Questionnaire is now the Patient-rated Tennis Elbow Evaluation</article-title>. <source>J Hand Ther</source>. <year>2005</year>;<volume>18</volume>:<fpage>407</fpage>-<lpage>410</lpage>.</citation>
</ref>
<ref id="bibr22-0363546513493767">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mishra</surname><given-names>A</given-names></name>
<name><surname>Pavelko</surname><given-names>T</given-names></name>
</person-group>. <article-title>Treatment of chronic elbow tendinosis with buffered platelet-rich plasma</article-title>. <source>Am J Sports Med</source>. <year>2006</year>;<volume>34</volume>:<fpage>1774</fpage>-<lpage>1778</lpage>.</citation>
</ref>
<ref id="bibr23-0363546513493767">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Peerbooms</surname><given-names>JC</given-names></name>
<name><surname>Sluimer</surname><given-names>J</given-names></name>
<name><surname>Bruijn</surname><given-names>DJ</given-names></name>
<name><surname>Gosens</surname><given-names>T</given-names></name>
</person-group>. <article-title>Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up</article-title>. <source>Am J Sports Med</source>. <year>2010</year>;<volume>38</volume>:<fpage>255</fpage>-<lpage>262</lpage>.</citation>
</ref>
<ref id="bibr24-0363546513493767">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rompe</surname><given-names>JD</given-names></name>
<name><surname>Overend</surname><given-names>TJ</given-names></name>
<name><surname>MacDermid</surname><given-names>JC</given-names></name>
</person-group>. <article-title>Validation of the Patient-rated Tennis Elbow Evaluation Questionnaire</article-title>. <source>J Hand Ther</source>. <year>2007</year>;<volume>20</volume>:<fpage>3</fpage>-<lpage>10</lpage>.</citation>
</ref>
<ref id="bibr25-0363546513493767">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schulz</surname><given-names>KF</given-names></name>
<name><surname>Altman</surname><given-names>DG</given-names></name>
<name><surname>Moher</surname><given-names>D</given-names></name>
</person-group>. <article-title>CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials</article-title>. <source>BMJ</source>. <year>2010</year>;<volume>340</volume>:<fpage>c332</fpage>.</citation>
</ref>
<ref id="bibr26-0363546513493767">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Smidt</surname><given-names>N</given-names></name>
<name><surname>Van der Windt</surname><given-names>DA</given-names></name>
<name><surname>Assendelft</surname><given-names>WJ</given-names></name>
<name><surname>Deville</surname><given-names>WL</given-names></name>
<name><surname>Korthals-de Bos</surname><given-names>IB</given-names></name>
<name><surname>Bouter</surname><given-names>LM</given-names></name>
</person-group>. <article-title>Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: a randomised controlled trial</article-title>. <source>Lancet</source>. <year>2002</year>;<volume>359</volume>:<fpage>657</fpage>-<lpage>662</lpage>.</citation>
</ref>
<ref id="bibr27-0363546513493767">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Thanasas</surname><given-names>C</given-names></name>
<name><surname>Papadimitriou</surname><given-names>G</given-names></name>
<name><surname>Charalambidis</surname><given-names>C</given-names></name>
<name><surname>Paraskevopoulos</surname><given-names>I</given-names></name>
<name><surname>Papanikolaou</surname><given-names>A</given-names></name>
</person-group>. <article-title>Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial</article-title>. <source>Am J Sports Med</source>. <year>2011</year>;<volume>39</volume>:<fpage>2130</fpage>-<lpage>2134</lpage>.</citation>
</ref>
</ref-list>
</back>
</sub-article>
</article>